Agarwal Shefali
CIK 0001746830
See RemarksDirector
Filings
15
Latest May 30, 2025
Issuers covered
3
Showing
15 of 15
Page 1
Track record
3 of 6 open-market trades scored (50% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -24.5% | -23.0% | -23.0% | -27.3% |
| 90 days | 3 | 0% | -10.9% | -14.3% | -4.2% | -14.3% |
| 180 days | 3 | 100% | +13.3% | +12.0% | +16.0% | +12.0% |
| 365 days | 3 | 100% | +77.9% | +78.2% | +78.2% | +77.5% |
Issuers
Companies where Agarwal Shefali has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 7 | May 30, 2025 |
| EPZM | Epizyme, Inc. | 4 | Mar 21, 2022 |
| GRTS | Gritstone Bio, Inc. | 4 | Apr 8, 2025 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|